CR20130087A - Compuestos de espiropiperidina como antagonistas del receptor orl-1 - Google Patents
Compuestos de espiropiperidina como antagonistas del receptor orl-1Info
- Publication number
- CR20130087A CR20130087A CR20130087A CR20130087A CR20130087A CR 20130087 A CR20130087 A CR 20130087A CR 20130087 A CR20130087 A CR 20130087A CR 20130087 A CR20130087 A CR 20130087A CR 20130087 A CR20130087 A CR 20130087A
- Authority
- CR
- Costa Rica
- Prior art keywords
- orl
- receptor
- spyropiperidine
- antrogonists
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a un antagonista del receptor ORL-1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09382246 | 2009-11-16 | ||
US29862910P | 2010-01-27 | 2010-01-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20130087A true CR20130087A (es) | 2013-04-17 |
Family
ID=41728051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20130087A CR20130087A (es) | 2009-11-16 | 2013-02-26 | Compuestos de espiropiperidina como antagonistas del receptor orl-1 |
Country Status (34)
Country | Link |
---|---|
US (1) | US8232289B2 (es) |
EP (1) | EP2501703B1 (es) |
JP (1) | JP5680101B2 (es) |
KR (1) | KR101363830B1 (es) |
CN (1) | CN102612520B (es) |
AR (1) | AR078863A1 (es) |
AU (1) | AU2010319581C1 (es) |
CA (1) | CA2796161C (es) |
CO (1) | CO6541545A2 (es) |
CR (1) | CR20130087A (es) |
DK (1) | DK2501703T3 (es) |
DO (1) | DOP2012000135A (es) |
EA (1) | EA020848B1 (es) |
EC (1) | ECSP12011902A (es) |
ES (1) | ES2435814T3 (es) |
HK (1) | HK1169988A1 (es) |
HN (1) | HN2012001011A (es) |
HR (1) | HRP20130967T1 (es) |
IL (1) | IL219370A (es) |
JO (1) | JO2887B1 (es) |
MA (1) | MA33751B1 (es) |
ME (1) | ME01537B (es) |
MX (1) | MX2012005691A (es) |
MY (1) | MY160665A (es) |
NZ (1) | NZ600006A (es) |
PE (1) | PE20121430A1 (es) |
PL (1) | PL2501703T3 (es) |
PT (1) | PT2501703E (es) |
RS (1) | RS53018B (es) |
SI (1) | SI2501703T1 (es) |
TW (1) | TWI465453B (es) |
UA (1) | UA107943C2 (es) |
WO (1) | WO2011060035A1 (es) |
ZA (1) | ZA201202967B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010325925B2 (en) | 2009-12-04 | 2016-02-25 | Pgi Drug Discovery Llc. | Multicyclic compounds and methods of use thereof |
US9394290B2 (en) * | 2010-10-21 | 2016-07-19 | Universitaet Des Saarlandes Campus Saarbruecken | Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases |
TWI582096B (zh) * | 2011-12-06 | 2017-05-11 | 美國禮來大藥廠 | 用於酒精依賴及濫用處理之4',5'-二氫螺[哌啶-4,7'-噻吩并[2,3-c]哌喃]化合物 |
TW201416370A (zh) | 2012-07-31 | 2014-05-01 | Lilly Co Eli | 用於治療焦慮之orl-1受體拮抗劑 |
JP6313312B2 (ja) | 2012-10-02 | 2018-04-18 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 農薬としての複素環化合物 |
US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環(4.5)癸烷衍生物 |
AR105821A1 (es) * | 2015-09-09 | 2017-11-15 | Lilly Co Eli | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T |
AU2017301767A1 (en) | 2016-07-29 | 2019-02-14 | Pgi Drug Discovery Llc | Compounds and compositions and uses thereof |
SG10202100724UA (en) | 2016-07-29 | 2021-03-30 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof |
CN110678205B (zh) | 2017-02-16 | 2023-05-23 | 桑诺维恩药品公司 | 治疗精神分裂症的方法 |
PT3589637T (pt) * | 2017-03-02 | 2021-06-02 | Lilly Co Eli | Compostos úteis para inibir ror-gamma-t |
HUE054483T2 (hu) | 2017-03-02 | 2021-09-28 | Lilly Co Eli | ROR-gamma-T gátlására alkalmas vegyületek |
EA202090414A1 (ru) | 2017-08-02 | 2020-05-28 | Суновион Фармасьютикалз Инк. | Соединения и их применение |
JP7453148B2 (ja) | 2018-02-16 | 2024-03-19 | サノビオン ファーマシューティカルズ インク | 塩、結晶形態、およびその製造方法 |
JOP20210131A1 (ar) | 2018-12-17 | 2023-01-30 | Vertex Pharma | مثبطات apol1 وطرق استخدامها |
MX2021010880A (es) | 2019-03-14 | 2022-01-18 | Sunovion Pharmaceuticals Inc | Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas. |
AU2021257786A1 (en) | 2020-04-14 | 2022-11-03 | Sunovion Pharmaceuticals Inc. | (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine for treating neurological and psychiatric disorders |
TW202227456A (zh) | 2020-08-26 | 2022-07-16 | 美商維泰克斯製藥公司 | Apol1抑制劑及其使用方法 |
WO2023154344A1 (en) * | 2022-02-08 | 2023-08-17 | Vertex Pharmaceuticals Incorporated | 2-methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL96507A0 (en) | 1989-12-08 | 1991-08-16 | Merck & Co Inc | Nitrogen-containing spirocycles and pharmaceutical compositions containing them |
DE60033071T2 (de) | 1999-12-06 | 2007-08-23 | Euro-Celtique S.A. | Triazospiroverbindungen mit nociceptin-rezeptoraffinität |
UA74439C2 (uk) | 2001-04-18 | 2005-12-15 | Еро-Селтік, С.А. | Сполуки спіропіразолу |
WO2002088089A1 (fr) | 2001-04-19 | 2002-11-07 | Banyu Pharmaceutical Co., Ltd. | Derives de spiropiperidine, antagonistes du recepteur de nociceptine les contenant en tant qu'ingredient actif et compositions medicinales |
ATE396995T1 (de) | 2001-07-23 | 2008-06-15 | Banyu Pharma Co Ltd | 4-oxoimidazolidin-2-spiro piperidin derivat |
EP1470126A1 (en) * | 2002-01-28 | 2004-10-27 | Pfizer Inc. | N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
JPWO2003095427A1 (ja) | 2002-05-10 | 2005-09-15 | 大正製薬株式会社 | スピロ環化合物 |
US6995168B2 (en) | 2002-05-31 | 2006-02-07 | Euro-Celtique S.A. | Triazaspiro compounds useful for treating or preventing pain |
NZ538307A (en) | 2002-09-09 | 2008-04-30 | Janssen Pharmaceutica Nv | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
WO2005016913A1 (en) * | 2003-08-19 | 2005-02-24 | Pfizer Japan, Inc. | Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
DE10360792A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
CA2561488A1 (en) * | 2004-03-29 | 2005-10-06 | Pfizer Inc. | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists |
DE102004039382A1 (de) * | 2004-08-13 | 2006-02-23 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
EP2020414A1 (en) | 2007-06-20 | 2009-02-04 | Laboratorios del Dr. Esteve S.A. | spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
PT2260042E (pt) | 2008-03-27 | 2011-12-06 | Gruenenthal Gmbh | Derivados de ciclo-hexano espirocíclicos substituídos |
-
2010
- 2010-10-11 UA UAA201205367A patent/UA107943C2/uk unknown
- 2010-11-02 AR ARP100104035A patent/AR078863A1/es active IP Right Grant
- 2010-11-03 JO JO2010386A patent/JO2887B1/en active
- 2010-11-05 TW TW099138241A patent/TWI465453B/zh not_active IP Right Cessation
- 2010-11-10 DK DK10782482.3T patent/DK2501703T3/da active
- 2010-11-10 MY MYPI2012002117A patent/MY160665A/en unknown
- 2010-11-10 ES ES10782482T patent/ES2435814T3/es active Active
- 2010-11-10 RS RS20130485A patent/RS53018B/en unknown
- 2010-11-10 NZ NZ600006A patent/NZ600006A/en not_active IP Right Cessation
- 2010-11-10 PE PE2012000659A patent/PE20121430A1/es active IP Right Grant
- 2010-11-10 US US12/943,187 patent/US8232289B2/en not_active Expired - Fee Related
- 2010-11-10 SI SI201030388T patent/SI2501703T1/sl unknown
- 2010-11-10 PL PL10782482T patent/PL2501703T3/pl unknown
- 2010-11-10 KR KR1020127012498A patent/KR101363830B1/ko active IP Right Grant
- 2010-11-10 EP EP10782482.3A patent/EP2501703B1/en active Active
- 2010-11-10 PT PT107824823T patent/PT2501703E/pt unknown
- 2010-11-10 ME MEP-2013-118A patent/ME01537B/me unknown
- 2010-11-10 JP JP2012538935A patent/JP5680101B2/ja not_active Expired - Fee Related
- 2010-11-10 EA EA201290352A patent/EA020848B1/ru not_active IP Right Cessation
- 2010-11-10 WO PCT/US2010/056180 patent/WO2011060035A1/en active Application Filing
- 2010-11-10 CA CA2796161A patent/CA2796161C/en not_active Expired - Fee Related
- 2010-11-10 CN CN201080051850.4A patent/CN102612520B/zh not_active Expired - Fee Related
- 2010-11-10 AU AU2010319581A patent/AU2010319581C1/en not_active Ceased
- 2010-11-10 MX MX2012005691A patent/MX2012005691A/es active IP Right Grant
-
2012
- 2012-04-23 IL IL219370A patent/IL219370A/en not_active IP Right Cessation
- 2012-04-23 ZA ZA2012/02967A patent/ZA201202967B/en unknown
- 2012-05-04 CO CO12073055A patent/CO6541545A2/es active IP Right Grant
- 2012-05-11 DO DO2012000135A patent/DOP2012000135A/es unknown
- 2012-05-11 HN HN2012001011A patent/HN2012001011A/es unknown
- 2012-05-14 MA MA34869A patent/MA33751B1/fr unknown
- 2012-05-16 EC ECSP12011902 patent/ECSP12011902A/es unknown
- 2012-10-26 HK HK12110735.5A patent/HK1169988A1/xx not_active IP Right Cessation
-
2013
- 2013-02-26 CR CR20130087A patent/CR20130087A/es unknown
- 2013-10-11 HR HRP20130967AT patent/HRP20130967T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20130087A (es) | Compuestos de espiropiperidina como antagonistas del receptor orl-1 | |
CR20120113A (es) | (heteroarilmetil)tiohidantoinas sustituidas como drogas anticancer | |
CR20150271A (es) | Peptidos como agonistas de oxitocina | |
HK1252279A1 (zh) | 5- ht3受體拮抗劑 | |
UY34798A (es) | Polipéptidos de unión a receptores de quimiocinas | |
DK2443104T3 (da) | Disubstituerede phthalazin-hedgehog-sti-antagonister | |
ME01665B (me) | Analozi buprenorfina | |
CR20130173A (es) | Lactamas sustituidas por piperidinilo como moduladores de gpr119 | |
SMT201600078B (it) | Antagonista del recettore per cgrp | |
CO6970595A2 (es) | Nuevos 2h-indazoles como antagonistas del receptor ep2 | |
CR20150084A (es) | 2-oxo-2,3-dihidro-indoles | |
CR20150144A (es) | Derivados de etinilo como moduladores del receptor de actividad mglur5 | |
CR20130625A (es) | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina | |
SMT201500293B (it) | Antagonisti del recettore toll-like 3 | |
SI2606042T1 (sl) | Disubstituirane tetrahidrofuranilne spojine kot antagonisti bradikininskega B1-receptorja | |
UY34349A (es) | OCTAHIDROPIRROLO[1,2-a]PIRAZINA SULFONAMIDAS SUSTITUIDAS COMO BLOQUEADORES DE CANALES DE CALCIO | |
CR20130597A (es) | Isoxazolinas como agentes terapèuticos | |
BRPI1013617A2 (pt) | derivados de piperidina como antagonistas de receptor de nk3 | |
CR20140531A (es) | Derivados de ariletinilo | |
UY34403A (es) | Preparación de liberación sostenida | |
BRPI1016115A2 (pt) | derivados de pirrolidina como antogonistas de receptador de nks. | |
CR20150028A (es) | Derivados de ariletinilo | |
BR112014027843A2 (pt) | análogos de hexa-depsipeptídeo como compostos anticancerígenos | |
CO6801772A2 (es) | Nuevos ácidos piperidinil-monocarboxilicos como agonistas del receptor de esfingosina-1-fosfato-1(s1p1) | |
UY34489A (es) | Derivados del ácido cicloalcanocarboxílico como antagonistas del receptor CXCR3 |